Aldeyra Therapeutics, Inc.

137.F·Frankfurt·Healthcare
Compare
0.6450−0.0100 (−1.53%)today
As of Oct 21, 8:10 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.6550
Open0.6450
Day range—
52-week range0.59004.8390
Off day high0.00%
Off 52-week high−86.67%
Volume1.00K
Avg. volume (3M)216
Market cap38.91M
EPS (TTM)-0.3300
Forward P/E-0.53
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.20
Shares outstanding60.33M
Short interest—
Earnings dateNov 4, 2026 (est.)
Analyst target—
Profit margin0.00%

Latest news

All 137.F news ›
MarketScreener·

Aldeyra Therapeutics, Inc. : Insider Transactions

Follow insider transactions on Aldeyra Therapeutics, Inc. in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Aldeyra Therapeutics, Inc. Biotechnology & Medical Research…

MarketScreener·

All Transcripts on Aldeyra Therapeutics, Inc. (ALDX)

Find all the latest transcripts on Aldeyra Therapeutics, Inc. Transcripts Aldeyra Therapeutics, Inc. Biotechnology & Medical Research All financial news and data tailored to specific country editions

MarketScreener·

Aldeyra Therapeutics, Inc.: Relative Strength Chart - Stock Nasdaq

Compare Aldeyra Therapeutics, Inc. with the company of your choice via a Relative Strength chart. Real-time ALDX price, Nasdaq stock exchange Relative Strength Chart Aldeyra Therapeutics, Inc. Biotechnology & Medical Research All financial…

From articles in the 4Search news index.

In the news

19mentions in 30 days
19with it in the headline
Negativesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 19 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.